Valuation West Pharmaceutical Services, Inc.
Stocks
WST
US9553061055
Medical Equipment, Supplies & Distribution
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 340.82 USD | +0.36% |
|
+3.76% | +23.76% |
Company Valuation: West Pharmaceutical Services, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 34,744 | 17,424 | 26,053 | 23,723 | 19,795 | 23,899 | - | - |
| Change | - | -49.85% | 49.53% | -8.95% | -16.56% | 20.74% | - | - |
| Enterprise Value (EV) 1 | 34,744 | 16,738 | 25,406 | 23,441 | 19,206 | 23,396 | 22,860 | 22,440 |
| Change | - | -51.82% | 51.78% | -7.74% | -18.07% | 21.81% | -2.29% | -1.83% |
| P/E | 54.1x | 30.4x | 44.7x | 49x | 40.5x | 39.6x | 34.4x | 30.8x |
| PBR | 14.9x | 6.5x | 8.98x | 8.83x | 5.95x | 7.63x | 6.66x | 5.89x |
| PEG | - | -2.8x | 23.04x | -3.2x | 27.09x | 1.5x | 2.3x | 2.6x |
| Capitalization / Revenue | 12.3x | 6.04x | 8.83x | 8.2x | 6.44x | 7.09x | 6.67x | 6.21x |
| EV / Revenue | 12.3x | 5.8x | 8.61x | 8.1x | 6.25x | 6.94x | 6.38x | 5.83x |
| EV / EBITDA | 39.3x | 19x | 30.7x | 32.2x | 24.2x | 24.8x | 21.9x | 19.3x |
| EV / EBIT | 45.6x | 22x | 36.8x | 40.9x | 30.9x | 31x | 27x | 23.7x |
| EV / FCF | 105x | 38.1x | 61.3x | 84.8x | 41x | 51.4x | 41.2x | 31x |
| FCF Yield | 0.95% | 2.63% | 1.63% | 1.18% | 2.44% | 1.94% | 2.43% | 3.23% |
| Dividend per Share 2 | 0.69 | 0.74 | 0.78 | 0.82 | 0.85 | 0.9028 | 0.9733 | 1.12 |
| Rate of return | 0.15% | 0.31% | 0.22% | 0.25% | 0.31% | 0.27% | 0.29% | 0.33% |
| EPS 2 | 8.67 | 7.73 | 7.88 | 6.69 | 6.79 | 8.575 | 9.865 | 11.04 |
| Distribution rate | 7.96% | 9.57% | 9.9% | 12.3% | 12.5% | 10.5% | 9.87% | 10.1% |
| Net sales 1 | 2,832 | 2,887 | 2,950 | 2,893 | 3,074 | 3,371 | 3,583 | 3,846 |
| EBITDA 1 | 884.7 | 882.6 | 827.9 | 728.2 | 793.8 | 941.8 | 1,042 | 1,160 |
| EBIT 1 | 762.4 | 762 | 690.6 | 572.8 | 622.4 | 755.9 | 846 | 948 |
| Net income 1 | 661.8 | 585.9 | 593.4 | 492.7 | 493.7 | 614.5 | 701.2 | 778 |
| Net Debt 1 | - | -685.4 | -647.1 | -282 | -588.5 | -503.3 | -1,039 | -1,458 |
| Reference price 2 | 469.01 | 235.35 | 352.12 | 327.56 | 275.14 | 339.59 | 339.59 | 339.59 |
| Nbr of stocks (in thousands) | 74,080 | 74,033 | 73,990 | 72,422 | 71,943 | 70,376 | - | - |
| Announcement Date | 17/02/22 | 16/02/23 | 15/02/24 | 13/02/25 | 12/02/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 39.6x | 6.94x | 24.84x | 0.27% | 23.9B | ||
| 30.24x | 4.11x | 15.98x | 2.44% | 183B | ||
| 19.42x | 3.39x | 11.94x | 3.47% | 110B | ||
| 17.37x | 0.19x | 12.26x | 0.76% | 60.75B | ||
| 30.04x | 7.29x | 19x | 1.33% | 50.01B | ||
| 36.03x | 3.22x | 10.97x | 2.37% | 45.59B | ||
| 37.5x | 1.37x | 12.06x | 0.21% | 33.08B | ||
| 30.28x | 5.41x | 17.22x | -.--% | 28.76B | ||
| 24.62x | 3.73x | 13.08x | 1.13% | 22.53B | ||
| 21.18x | 2.93x | 11.3x | 1.49% | 22.35B | ||
| Average | 28.63x | 3.86x | 14.86x | 1.35% | 57.94B | |
| Weighted average by Cap. | 27.51x | 3.73x | 14.60x | 1.93% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- WST Stock
- Valuation West Pharmaceutical Services, Inc.
Select your edition
All financial news and data tailored to specific country editions
















